XML 105 R85.htm IDEA: XBRL DOCUMENT v3.8.0.1

SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details) $ in Thousands	3 Months Ended							6 Months Ended	12 Months Ended
	Mar. 31, 2018 USD ($)	Dec. 30, 2017 USD ($)	Jul. 01, 2017 USD ($)	Apr. 01, 2017 USD ($)	Dec. 31, 2016 USD ($)	Oct. 01, 2016 USD ($)	Jul. 02, 2016 USD ($)	Sep. 30, 2017 USD ($)	Mar. 31, 2018 USD ($) unit	Apr. 01, 2017 USD ($)	Apr. 02, 2016 USD ($)
Segment Reporting Information [Line Items]
Number of business units | unit									4
Net revenues before foreign exchange impact									$ 909,317	$ 899,580	$ 910,515
Effect of exchange rates									(5,394)	(13,464)	(1,683)
Net revenues	$ 233,552	$ 234,043	$ 210,951	$ 228,066	$ 227,841	$ 220,253	$ 209,956	$ 225,377	903,923	886,116	908,832
Operating income	14,275	$ 1,013	$ 16,611	(57,506)	$ 21,212	$ 24,794	$ (7,881)	$ 24,258	56,157	(19,381)	(43,942)
Effect of exchange rates									4,059	(4,772)	3,546
Restructuring and turnaround costs									(44,125)	(34,337)	(42,185)
Deal amortization									(26,013)	(27,107)	(28,958)
Impairment of assets									(1,941)	(73,353)	(97,230)
Legal charges									(3,011)	0	0
Contingent consideration income									0	0	4,727
Depreciation and amortization									89,247	89,733	89,911
Total long-lived assets	332,156			323,862					332,156	323,862	337,634
Plasma
Segment Reporting Information [Line Items]
Net revenues									435,956	410,727	381,776
Blood Center
Segment Reporting Information [Line Items]
Net revenues									284,902	303,890	355,108
Cell Processing
Segment Reporting Information [Line Items]
Net revenues									107,562	105,376	112,483
Hemostasis Management
Segment Reporting Information [Line Items]
Net revenues									75,503	66,123	59,465
United States
Segment Reporting Information [Line Items]
Net revenues									548,731	522,686	519,440
Total long-lived assets	236,603			241,610					236,603	241,610	231,744
Japan
Segment Reporting Information [Line Items]
Net revenues									67,319	79,266	81,411
Total long-lived assets	1,511			1,691					1,511	1,691	2,022
Europe
Segment Reporting Information [Line Items]
Net revenues									164,226	166,007	187,725
Total long-lived assets	13,696			12,952					13,696	12,952	18,672
Asia
Segment Reporting Information [Line Items]
Net revenues									115,127	109,858	111,758
Total long-lived assets	36,431			34,174					36,431	34,174	40,235
Other
Segment Reporting Information [Line Items]
Net revenues									8,520	8,299	8,498
Total long-lived assets	43,915			33,435					43,915	33,435	44,961
Japan
Segment Reporting Information [Line Items]
Net revenues before foreign exchange impact									68,172	74,695	84,270
Depreciation and amortization									486	827	774
Total long-lived assets	26,640			21,412					26,640	21,412	33,159
EMEA
Segment Reporting Information [Line Items]
Net revenues before foreign exchange impact									183,301	198,396	204,192
Depreciation and amortization									4,464	4,255	5,146
Total long-lived assets	74,783			63,854					74,783	63,854	63,861
North America Plasma
Segment Reporting Information [Line Items]
Net revenues before foreign exchange impact									333,831	309,718	279,803
Depreciation and amortization									16,060	13,022	12,944
Total long-lived assets	91,815			142,164					91,815	142,164	116,001
All Other
Segment Reporting Information [Line Items]
Net revenues before foreign exchange impact									324,013	316,771	342,249
Depreciation and amortization									68,237	71,629	71,047
Total long-lived assets	$ 138,918			$ 96,432					138,918	96,432	124,613
Operating Segments [Member]
Segment Reporting Information [Line Items]
Operating income									347,887	331,669	343,997
Operating Segments [Member] | Japan
Segment Reporting Information [Line Items]
Operating income									37,243	39,892	43,619
Operating Segments [Member] | EMEA
Segment Reporting Information [Line Items]
Operating income									62,696	65,689	63,665
Operating Segments [Member] | North America Plasma
Segment Reporting Information [Line Items]
Operating income									119,003	98,254	109,220
Operating Segments [Member] | All Other
Segment Reporting Information [Line Items]
Operating income									128,945	127,834	127,493
Corporate, Non-Segment [Member]
Segment Reporting Information [Line Items]
Corporate operating expenses									$ (220,699)	$ (211,481)	$ (227,839)

X

- Definition

Corporate Operating Expenses

+ References

No definition available.

+ Details

Name:	hae_CorporateOperatingExpenses
Namespace Prefix:	hae_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Effect of Exchange Rate on Revenues

+ References

No definition available.

+ Details

Name:	hae_EffectofExchangeRateonRevenues
Namespace Prefix:	hae_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Effect of Exchange Rates on Operating Income

+ References

No definition available.

+ Details

Name:	hae_EffectofExchangeRatesonOperatingIncome
Namespace Prefix:	hae_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Net Revenues, Before Foreign Exchange Impact

+ References

No definition available.

+ Details

Name:	hae_NetRevenuesBeforeForeignExchangeImpact
Namespace Prefix:	hae_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Restructuring and Turnaround Costs

+ References

No definition available.

+ Details

Name:	hae_RestructuringandTurnaroundCosts
Namespace Prefix:	hae_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

+ Details

Name:	us-gaap_AdjustmentForAmortization
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 4
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479

+ Details

Name:	us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

+ Details

Name:	us-gaap_DepreciationAndAmortization
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.3)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

+ Details

Name:	us-gaap_LegalFees
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9038-108599

+ Details

Name:	us-gaap_NoncurrentAssets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Reporting Unit
-URI http://asc.fasb.org/extlink&oid=6523643

+ Details

Name:	us-gaap_NumberOfReportingUnits
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The net result for the period of deducting operating expenses from operating revenues.

+ References

No definition available.

+ Details

Name:	us-gaap_OperatingIncomeLoss
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=64862545&loc=d3e2921-110230

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

+ Details

Name:	us-gaap_OtherAssetImpairmentCharges
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1(a))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

+ Details

Name:	us-gaap_SalesRevenueGoodsNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingInformationLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_ProductOrServiceAxis=hae_PlasmaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ProductOrServiceAxis=hae_BloodCenterMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ProductOrServiceAxis=hae_CellProcessingMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ProductOrServiceAxis=hae_HemostasisManagementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementGeographicalAxis=country_US
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementGeographicalAxis=country_JP
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementGeographicalAxis=us-gaap_EuropeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementGeographicalAxis=us-gaap_AsiaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementGeographicalAxis=hae_OtherCountryorRegionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=country_JP
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=us-gaap_EMEAMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=hae_NorthAmericaPlasmaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=hae_AmericasBloodCenterandHospitalandAsiaPacificMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: